| Literature DB >> 35586738 |
Lihu Gu1, Rongrong Fu2, Jiaze Hong3, Haixiang Ni4, Kepin Yu2, Haiying Lou5.
Abstract
Background: The popularity of applying intermittent fasting (IF) has increased as more and more people are trying to avoid or alleviate obesity and metabolic disease. This study aimed to systematically explore the effects of various IF in humans.Entities:
Keywords: caloric restriction; effect; intermittent fasting; meta-analysis; non-intervention diet
Year: 2022 PMID: 35586738 PMCID: PMC9108547 DOI: 10.3389/fnut.2022.871682
Source DB: PubMed Journal: Front Nutr ISSN: 2296-861X
Figure 1The flowchart for the retrieval process included studies in this meta-analysis.
Characteristics of included RCTs in the meta-analysis.
|
|
|
|
|
|
|
| ||
|---|---|---|---|---|---|---|---|---|
|
|
|
|
| |||||
| Antoni et al. ( | UK | ISRCTN13687043 | BMI>25 kg/m2; Age: 18–65 years | IER (2:5 diet) | 24 | CER | 24 | 16 |
| Beaulieu et al. ( | UK | NCT03447600 | BMI: 25–34.9 kg/m2; Age: 18–55 years | ADF | 24 | CER | 22 | 10 |
| Bhutani et al. ( | USA | NA | BMI: 30–39.9 kg/m2; Age: 25–65 years | ADF | 25 | Non-intervention diet | 16 | 3 |
| Bowen et al. ( | Australia | ACTRN12616000110482 | BMI > 27 kg/m2; Age: 25–60 years | ADF+DER | 82 | DER | 81 | 4 |
| Cai et al. ( | China | ChiCTR1900024411 | BMI > 24 kg/m2 with NAFLD; Age: 18–65 years | ADF | 95 | Non-intervention diet | 79 | 3 |
| TRF (16:8 diet) | 97 | |||||||
| Carlson et al. ( | USA | NA | BMI: 18–25 kg/m2; Age: 40–50 years | TRF (20:4 diet) | 15 | Non-intervention diet | 15 | 4 |
| Catenacci et al. ( | USA | NA | BMI ≥ 30 kg/m2; Age: 18–55 years | ADF | 15 | CR | 14 | 8 |
| Chow et al. ( | USA | NCT03129581 | BMI ≥ 25 kg/m2; Age: 18–65 years | TRF (16:8 diet) | 13 | Non-intervention diet | 9 | 3 |
| Cienfuegos et al. ( | USA | NCT03867773 | BMI: 30–49.9 kg/m2; Age: 18–65 years | TRF (20:4 diet) | 19 | Non-intervention diet | 19 | 2 |
| TRF (18:6 diet) | 20 | |||||||
| Conley et al. ( | Australia | ACTRN12614000396628 | BMI ≥ 30 kg/m2; Age: 55–75 years | IER (2:5 diet) | 12 | CR | 12 | 6 |
| Corley et al. ( | New Zealand | ACTRN12614000402640 | BMI: 30–45 kg/m2 with T2DM; Age > 18 years | TRF (2:5 diet) | 22 | CR | 19 | 4 |
| Correia et al. ( | USA | NA | Age: 18–30 years | TRF (16:8 diet) | 9 | Non-intervention diet | 9 | 1 |
| Coutinho et al. ( | Norway | NCT02169778 | BMI: 30–40 kg/m2; Age: 18–65 years | IER (3:4 diet) | 18 | CER | 17 | 3 |
| de Oliveira Maranhão Pureza et al. ( | Brazil | NA | BMI: 30–45kg/m2 | TRF+CR (12:12 diet) | 31 | CR | 27 | 12 |
| Gabel et al. ( | USA | NCT00960505 | BMI: 25–39.9 kg/m2; Age: 18–65 years | ADF | 34 | CR | 35 | 12 |
| Non-intervention diet | 31 | |||||||
| Guo et al. ( | China | NCT03608800 | Age: 30–50 years with comorbidities | IF (2:5 diet) | 23 | Non-intervention diet | 23 | 2 |
| Harvie et al. ( | UK | NA | BMI: 24–40kg/m2; Age: 30–45 years | IER (2:5 diet) | 53 | CER | 54 | 6 |
| Harvie et al. ( | USA | ISRCTN52913838 | BMI: 24–45 kg/m2; Age:20–65 years | IECR (2:5 diet) | 37 | DER | 40 | 16 |
| Headland et al. ( | Australia | ACTRN12614001041640 | BMI ≥ 27 kg/m2; Age>18 years | IER (2:5 diet) | 82 | CER | 81 | 13 |
| Hirsh et al. ( | USA | NCT03372109 | BMI: 25–29.9 kg/m2; Age: 21–65 years | IF (2:5 diet) | 10 | Non-intervention diet | 12 | 2 |
| Kotarsky et al. ( | USA | NCT03823872 | BMI: 25–34.9 kg/m2; Age: 35–65 years | TRF (16:8 diet) | 13 | Non-intervention diet | 10 | 14 |
| Kunduraci et al. ( | Turkey | NCT04502329 | BMI ≥ 27 kg/m2 with comorbidities; Age: 18–65 years | IER (16:8 diet) | 35 | CER | 35 | 3 |
| Lowe et al. ( | USA | NCT03393195 | Age: 18–64 | TRF (16:8 diet) | 69 | Non-intervention diet | 72 | 3 |
| Martens et al. ( | USA | NCT02970188 | BMI <40 kg/m2; Age: 55–79 years | TRF (16:8 diet) | 24 | CR | 24 | 2 |
| Martínez-Rodríguez et al. ( | Spain | NCT04404413 | NA | IF | 14 | Non-intervention diet | 14 | 4 |
| McAllister et al. ( | USA | NA | NA | TRF (16:8 diet) | 11 | Non-intervention diet | 12 | 1 |
| Moro et al. ( | Italy | NA | NA | TRF (16:8 diet) | 17 | Non-intervention diet | 17 | 2 |
| Moro et al. ( | Italy | NCT04320784 | Age <23 years | TRF (16:8 diet) | 8 | Non-intervention diet | 8 | 1 |
| Oh et al. ( | Korea | NCT03652532 | BMI > 23 kg/m2; Age: 18–64 years | ADF+CR | 13 | CR | 10 | 2 |
| Panizza et al. ( | USA | NCT03639350 | BMI: 25–40 kg/m2; Age: 35–55 years | IER+MED (2:5 diet) | 30 | DASH | 30 | 6 |
| Parvaresh et al. ( | Iran | IRCT201509092395N8 | BMI: 25–40 kg/m2; Age: 25–60 years | ADF | 35 | CR | 35 | 2 |
| Pureza et al. ( | Brazil | RBR-387v6v | BMI: 30–45 kg/m2 | TRF+CR (12:12 diet) | 31 | CR | 27 | 1 |
| Razavi et al. ( | Iran | NA | BMI: 25–40 kg/m2 with MetS; Age: 25–60 years | ADF | 40 | CR | 40 | 4 |
| Schübel et al. ( | Germany | NCT02449148 | BMI: 25–40 kg/m2; Age: 35–65 years | ICR (2:5 diet) | 45 | CR | 49 | 12 |
| Non-intervention diet | 52 | |||||||
| Stote et al. ( | USA | NA | BMI: 18–25 kg/m2; Age: 40–50 years | TRF (20:4 diet) | 15 | Non-intervention diet | 15 | 6 |
| Teng et al. ( | Malaysia | NA | BMI: 23–29.9 kg/m2; Age: 50–70 years | FCR (2:5 diet) | 14 | Non-intervention diet | 14 | 3 |
| Teng et al. ( | Malaysia | NA | BMI: 23–29.9 kg/m2; Age: 50–70 years | FCR (2:5 diet) | 28 | Non-intervention diet | 28 | 3 |
| Tinsley et al. ( | USA | NA | NA | TRF (20:4 diet + 4:3 diet) | 14 | Non-intervention diet | 14 | 2 |
| Tinsley et al. ( | USA | NCT03404271 | Age: 18–30 years | TRF (16:8 diet) | 13 | Non-intervention diet | 14 | 2 |
| Trabelsi et al. ( | Tunisia | NA | NA | Ramadan | 10 | Non-intervention diet | 9 | 1 |
| Trabelsi et al. ( | Tunisia | NA | NA | Ramadan | 8 | Non-intervention diet | 8 | 1 |
| Varady et al. ( | USA | NA | BMI: 20–29.9 kg/m2; Age: 35–65 years | ADF | 16 | Non-intervention diet | 16 | 3 |
| Zouhal et al. ( | Tunisia | NA | BMI: 30–40 kg/m2 | Ramadan | 14 | Non-intervention diet | 14 | 1 |
RCT, randomized controlled trial; IER, intermittent energy restriction; ADF, alternate-day fasting; DER, daily energy restriction; TRF, time-restricted feeding; NAFLD, nonalcoholic fatty liver disease; IF, intermittent fasting; CR, calorie restriction; MED, Mediterranean diet; MetS, metabolic syndrome; ICR, intermittent calorie restriction; FCR, Muslim sunnah fasting; UK, United Kingdom; USA, the United States; BMI, body mass index; NA, no available; CER, continuous energy restriction; ICER, intermittent energy and carbohydrate restriction; DASH, Dietary Approaches to Stop Hypertension; 2:5 diet, 2-day fasting per week; 16:8 diet, 16-h fasting per day; 20:8 diet, 20-h fasting per day; 18:6 diet, 18-h fasting per day; 3:4 diet, 3-day fasting per week; 12:12 diet, 12-h fasting per day; 4:3 diet, 4-day fasting per week; N, number of patients.
Figure 2Forest plots for the body mass index (BMI) and waist circumference (WC) of intermittent fasting (IF) vs. non-intervention diet. (A) BMI; (B) WC.
Figure 3Forest plots for the fat mass (FM) and fat-free mass (FFM) of the IF vs. non-intervention diet. (A) FM; (B) FFM.
Figure 4Forest plots for the glucose, insulin, and homeostasis model assessment insulin resistance (HOMA-IR) of IF vs. non-intervention diet. (A) Glucose; (B) insulin; (C) HOMA-IR.
Figure 5Forest plots for the triglyceride (TG) and total cholesterol (TC) of IF vs. non-intervention diet. (A) TG; (B) TC.
Physical and biochemical parameters of IF vs. CR.
|
|
|
|
|
|
| |
|---|---|---|---|---|---|---|
| Weight | 6 | 2.08 | −0.61–4.77 | 0.13 | 22 | Fixed |
| BMI | 11 | 0.35 | −0.64–1.34 | 0.49 | 57 | Random |
| WC | 10 | 2.29 | 0.57–4.01 |
| 35 | Fixed |
| FM(kg) | 12 | 1.96 | −0.34–4.27 | 0.09 | 72 | Random |
| FM% | 8 | 0.77 | −0.62–2.16 | 0.28 | 5 | Fixed |
| FFM(kg) | 10 | 0.65 | −0.51–1.81 | 0.27 | 0 | Fixed |
| SBP | 9 | 1.75 | −0.41–3.90 | 0.11 | 45 | Fixed |
| DBP | 9 | 1.06 | −0.53–2.65 | 0.19 | 0 | Fixed |
| Glucose | 12 | −0.01 | −0.16–0.14 | 0.87 | 22 | Fixed |
| Insulin | 10 | 0.07 | −0.09–0.22 | 0.40 | 44 | Fixed |
| HOMA-IR | 7 | 0.00 | −0.31–0.32 | 0.99 | 54 | Random |
| TG | 10 | 0.03 | −0.14–0.19 | 0.76 | 20 | Fixed |
| TC | 10 | 0.08 | −0.09–0.24 | 0.35 | 0 | Fixed |
| LDL | 9 | 0.06 | −0.11–0.23 | 0.49 | 0 | Fixed |
CR, calorie restriction; IF, intermittent fasting; BMI: body mass index; WC, waist circumference; FM, fat mass; FFM, fat-free mass; SBP, systolic blood pressure; DBP, diastolic blood pressure; HOMA-IR, homeostasis model assessment insulin resistance; TC, total cholesterol; TG, triglyceride; LDL, low-density lipoprotein; SMD, standard mean difference; WMD, weighted mean difference; CI, confidence interval. SMD: glucose, insulin, TG, TC, and LDL; WMD: weight, BMI, WC, FM (kg), FM%, FFM (kg), SBP, DBP, and HOMA-IR.
Bold indicates statistically significant differences (P < 0.05).
Physical and biochemical parameters of ADF vs. CR and TRF (week) vs. CR.
|
|
|
|
|
|
| |
|---|---|---|---|---|---|---|
|
| ||||||
| Weight | 6 | 2.09 | −2.91–7.10 | 0.41 | 63 | Random |
| BMI | 5 | 0.66 | −0.24–1.57 | 0.15 | 45 | Fixed |
| WC | 3 | 1.37 | −1.34–4.08 | 0.32 | 28 | Fixed |
| FM(kg) | 6 | 2.80 | −0.74–6.34 | 0.12 | 78 | Random |
| FM% | 3 | 1.11 | −1.00–3.23 | 0.30 | 38 | Fixed |
| FFM(kg) | 4 | 0.23 | −1.64–2.11 | 0.81 | 0 | Fixed |
| SBP | 3 | 4.34 | −5.83–14.50 | 0.40 | 79 | Random |
| DBP | 3 | −0.03 | −2.47–2.41 | 0.98 | 0 | Fixed |
| Glucose | 4 | 0.10 | −0.32–0.53 | 0.63 | 56 | Random |
| Insulin | 4 | 0.25 | −0.23–0.73 | 0.31 | 65 | Random |
| TG | 4 | −0.01 | −0.25–0.24 | 0.96 | 28 | Fixed |
| TC | 4 | 0.04 | −0.21–0.28 | 0.78 | 0 | Fixed |
| LDL | 4 | 0.05 | −0.19–0.30 | 0.68 | 0 | Fixed |
| HDL | 4 | −0.08 | −0.59–0.44 | 0.77 | 71 | Random |
|
| ||||||
| Weight | 8 | 2.41 | −0.33–5.14 | 0.08 | 42 | Fixed |
| BMI | 4 | 0.66 | −0.91–2.22 | 0.41 | 51 | Random |
| WC | 6 | 3.66 | 1.24–6.08 |
| 38 | Fixed |
| FM(kg) | 5 | 2.58 | 0.61–4.55 |
| 45 | Fixed |
| FM% | 4 | 1.42 | −0.68–3.53 | 0.18 | 0 | Fixed |
| FFM(kg) | 5 | 1.27 | −0.29–2.82 | 0.11 | 2 | Fixed |
| SBP | 4 | 3.19 | −1.26–7.63 | 0.16 | 0 | Fixed |
| DBP | 4 | 3.47 | −0.06–7.00 |
| 0 | Fixed |
| Glucose | 6 | −0.08 | −0.29–0.14 | 0.49 | 14 | Fixed |
| Insulin | 4 | 0.05 | −0.34–0.43 | 0.81 | 59 | Random |
| TG | 5 | 0.11 | −0.14–0.36 | 0.39 | 33 | Fixed |
| TC | 4 | 0.13 | −0.13–0.40 | 0.33 | 0 | Fixed |
| LDL | 4 | 0.07 | −0.20–0.33 | 0.63 | 0 | Fixed |
| HDL | 4 | −0.07 | −0.34–0.19 | 0.60 | 0 | Fixed |
CR, calorie restriction; ADF, alternate-day fasting; TRF, time-restricted feeding; BMI: body mass index; WC, waist circumference; FM, fat mass; FFM, fat-free mass; SBP, systolic blood pressure; DBP, diastolic blood pressure; TC, total cholesterol; TG, triglyceride; LDL, low-density lipoprotein; HDL, high-density lipoprotein; SMD, standard mean difference; WMD, weighted mean difference; CI, confidence interval. SMD: glucose, insulin, TG, TC, LDL, and HDL; WMD: weight, BMI, WC, FM (kg), FM%, FFM (kg), SBP, and DBP.
Bold indicates statistically significant differences (P < 0.05).
Physical and biochemical parameters of IF vs. non-intervention diet/CR in women and men.
|
|
|
|
|
|
| |
|---|---|---|---|---|---|---|
|
| ||||||
| Weight | 6 | 2.08 | −0.61–4.77 | 0.13 | 22 | Fixed |
| WC | 5 | 1.80 | −1.53–5.13 | 0.29 | 50 | Random |
| FM(kg) | 5 | 3.72 | 0.56–6.87 |
| 67 | Random |
| FM% | 3 | 0.68 | −1.45–2.80 | 0.53 | 0 | Fixed |
| FFM(kg) | 4 | 1.10 | −0.37–2.57 | 0.14 | 0 | Fixed |
| Glucose | 3 | −0.00 | −0.17–0.17 | 1.00 | 0 | Fixed |
| Insulin | 3 | 0.92 | −0.21–2.06 | 0.11 | 0 | Fixed |
|
| ||||||
| Weight | 8 | 2.16 | 0.48–3.85 |
| 29 | Fixed |
| BMI | 4 | 0.97 | 0.23–1.71 |
| 0 | Fixed |
| FM(kg) | 4 | 0.98 | −0.38–2.35 | 0.16 | 0 | Fixed |
| FM% | 7 | 0.40 | −0.12–0.92 | 0.14 | 0 | Fixed |
| FFM(kg) | 6 | 0.37 | −0.98–1.72 | 0.59 | 0 | Fixed |
| Glucose | 6 | 0.09 | −0.21–0.40 | 0.55 | 0 | Fixed |
| TG | 6 | 0.54 | 0.22–0.86 |
| 31 | Fixed |
| TC | 6 | 0.15 | −0.16–0.45 | 0.36 | 0 | Fixed |
| LDL | 5 | 0.17 | −0.16–0.49 | 0.32 | 19 | Fixed |
| HDL | 5 | −0.09 | −0.41–0.24 | 0.60 | 0 | Fixed |
CR, calorie restriction; IF, intermittent fasting; BMI: body mass index; WC, waist circumference; FM, fat mass; FFM, fat-free mass; TC, total cholesterol; TG, triglyceride; LDL, low-density lipoprotein; HDL, high-density lipoprotein; SMD, standard mean difference; WMD, weighted mean difference; CI, confidence interval. SMD: glucose (men), TG, TC, and LDL; WMD: weight, BMI, WC, FM (kg), FM%, FFM (kg), glucose (women), and insulin.
Bold indicates statistically significant differences (P < 0.05).
Physical and biochemical parameters of IF vs. non-intervention diet in patients with BMI ≥ 25 kg/m2.
|
|
|
|
|
|
| |
|---|---|---|---|---|---|---|
| Weight | 6 | 3.42 | −0.77–7.61 | 0.11 | 0 | Fixed |
| BMI | 3 | 1.39 | −0.12–2.90 | 0.07 | 0 | Fixed |
| FM(kg) | 5 | 2.52 | −1.22–6.26 | 0.19 | 0 | Fixed |
| FFM(kg) | 4 | 0.72 | −2.51–3.94 | 0.66 | 0 | Fixed |
| SBP | 5 | 1.63 | −3.12–6.37 | 0.50 | 0 | Fixed |
| DBP | 5 | 0.65 | −2.52–3.81 | 0.69 | 7 | Fixed |
| Glucose | 4 | 0.33 | −2.36–3.02 | 0.81 | 39 | Fixed |
| Insulin | 6 | 1.46 | −0.36–3.29 | 0.12 | 0 | Fixed |
| HOMA–IR | 5 | 0.43 | 0.04–0.83 |
| 0 | Fixed |
| TG | 5 | 7.70 | −3.85–19.26 | 0.19 | 33 | Fixed |
| TC | 5 | 2.81 | −7.36–12.99 | 0.59 | 0 | Fixed |
| LDL | 5 | 4.73 | −3.32–12.79 | 0.25 | 0 | Fixed |
| HDL | 6 | 0.40 | −3.06–3.86 | 0.82 | 49 | Fixed |
IF, intermittent fasting; BMI: body mass index; FM, fat mass; FFM, fat-free mass; SBP, systolic blood pressure; DBP, diastolic blood pressure; HOMA-IR, homeostasis model assessment insulin resistance; TC, total cholesterol; TG, triglyceride; LDL, low-density lipoprotein; HDL, high-density lipoprotein; WMD, weighted mean difference; CI, confidence interval.
Bold indicates statistically significant differences (P < 0.05).
Physical and biochemical parameters of IF vs. CR in patients with BMI ≥25 kg/m2.
|
|
|
|
|
|
| |
|---|---|---|---|---|---|---|
| Weight | 13 | 0.25 | −2.88–3.37 | 0.88 | 52 | Random |
| BMI | 11 | 0.35 | −0.64–1.34 | 0.49 | 57 | Random |
| WC | 7 | 1.58 | −0.60–3.76 | 0.16 | 36 | Fixed |
| FM(kg) | 9 | 1.61 | −1.32–4.54 | 0.28 | 74 | Random |
| FM% | 6 | 0.54 | −1.13–2.21 | 0.53 | 26 | Fixed |
| FFM(kg) | 8 | −0.13 | −1.70–1.44 | 0.87 | 0 | Fixed |
| SBP | 9 | 1.75 | −0.41–3.90 | 0.11 | 45 | Fixed |
| DBP | 9 | 1.06 | −0.53–2.65 | 0.19 | 0 | Fixed |
| Glucose | 10 | 0.05 | −0.12–0.23 | 0.55 | 16 | Fixed |
| Insulin | 9 | 0.02 | −0.15–0.19 | 0.82 | 42 | Fixed |
| HOMA-IR | 6 | −0.18 | −0.39–0.03 | 0.10 | 46 | Fixed |
| TG | 10 | 0.03 | −0.14–0.19 | 0.76 | 20 | Fixed |
| TC | 9 | 0.08 | −0.09–0.25 | 0.35 | 0 | Fixed |
| LDL | 9 | 0.06 | −0.11–0.23 | 0.49 | 0 | Fixed |
| HDL | 9 | 0.02 | −0.15–0.19 | 0.79 | 42 | Fixed |
CR, calorie restriction; IF, intermittent fasting; BMI: body mass index; WC, waist circumference; FM, fat mass; FFM, fat-free mass; SBP, systolic blood pressure; DBP, diastolic blood pressure; HOMA-IR, homeostasis model assessment insulin resistance; TC, total cholesterol; TG, triglyceride; LDL, low-density lipoprotein; HDL, high-density lipoprotein; SMD, standard mean difference; WMD, weighted mean difference; CI, confidence interval. SMD: glucose, insulin, TG, TC, LDL, and HDL; WMD: weight, BMI, WC, FM (kg), FM%, FFM (kg), SBP, DBP, and HOMA-IR.